Evidence map›Paper›PMID 33250963›Full record

ArticleWorld journal of gastrointestinal oncology2020

Highly accurate colorectal cancer prediction model based on Raman spectroscopy using patient serum.

Hiroaki Ito, Naoyuki Uragami, Tomokazu Miyazaki, William Yang, Kenji Issha, Kai Matsuo, Satoshi Kimura, Yuji Arai, Hiromasa Tokunaga, Saiko Okada and 6 more

Open access · diamondAbstract read
In one paragraph

Article in World journal of gastrointestinal oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Current Trends of Raman Spectroscopy in Clinic Settings: Opportunities and Challenges.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Hiroaki ItoDigestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan. h.ito@med.showa-u.ac.jp.
Naoyuki UragamiDigestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Tomokazu MiyazakiResearch Division, JSR Corporation, Tokyo 105-0021, Japan.
William YangBaySpec Inc., San Jose, CA 95131, United States.
Kenji IsshaFuji Technical Research Inc., Yokohama 220-6215, Japan.
Kai MatsuoDigestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Satoshi KimuraDepartment of Laboratory Medicine and Central Clinical Laboratory, Showa University Northern Yokohama Hospital, Yokohama 224-8503, Japan.
Yuji AraiDepartment of Clinical Laboratory, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Hiromasa TokunagaDepartment of Clinical Laboratory, Showa University Hospital, Tokyo 142-8555, Japan, BML Inc., Tokyo 151-0051, Japan.
Saiko OkadaDepartment of Clinical Laboratory, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Machiko KawamuraDepartment of Hematology, Saitama Cancer Center, Inamachi, Saitama 362-0806, Japan.
Noboru YokoyamaDigestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Miki KushimaDepartment of Pathology, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Haruhiro InoueDigestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Takashi FukagaiDepartment of Urology, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Yumi KamijoShowa University Koto Toyosu Hospital, Tokyo 135-8577, Japan.
Showa University · JPShowa University Northern Yokohama Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is an important disease worldwide, accounting for the second highest number of cancer-related deaths and the third highest number of new cancer cases. The blood test is a simple and minimally invasive diagnostic test. However, there is currently no blood test that can accurately diagnose CRC.

aimTo develop a comprehensive, spontaneous, minimally invasive, label-free, blood-based CRC screening technique based on Raman spectroscopy.

methodsWe used Raman spectra recorded using 184 serum samples obtained from patients undergoing colonoscopies. Patients with malignant tumor histories as well as those with cancers in organs other than the large intestine were excluded. Consequently, the specific diseases of 184 patients were CRC (12), rectal neuroendocrine tumor (2), colorectal adenoma (68), colorectal hyperplastic polyp (18), and others (84). We used the 1064-nm wavelength laser for excitation. The power of the laser was set to 200 mW.

resultsUse of the recorded Raman spectra as training data allowed the construction of a boosted tree CRC prediction model based on machine learning. Therefore, the generalized

conclusionFor machine learning using Raman spectral data, a highly accurate CRC prediction model with a high

Indexed as

BloodColorectal cancerDiagnosisMachine learningRaman spectroscopySerum

Identifiers

PMID33250963
PMCPMC7667458
OpenAlexW3103587427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.